Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.10
Bid: 32.95
Ask: 33.85
Change: -0.60 (-1.78%)
Spread: 0.90 (2.731%)
Open: 33.95
High: 33.95
Low: 32.95
Prev. Close: 33.70
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Morgan Stanley upgrades BT to Overweight

Mon, 29th Mar 2021 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

MORGAN STANLEY RAISES BT GROUP TO 'OVERWEIGHT' (EQUAL-WEIGHT) - PRICE TARGET 200 (125) PENCE

----------

HSBC CUTS BERKELEY GROUP TO 'REDUCE' ('BUY') - TARGET 3,940 (5,920) PENCE

----------

JPMORGAN RAISES TAYLOR WIMPEY TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 220 (190) PENCE

----------

JPMORGAN RAISES PERSIMMON PRICE TARGET TO 3,420 (3,360) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 5,100 (4,900) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BARRATT DEVELOPMENTS TO 'NEUTRAL' ('OVERWEIGHT') TARGET 850 (800) PENCE

----------

UBS RAISES WHITBREAD PRICE TARGET TO 3,900 (3,550) PENCE - 'BUY'

----------

UBS RAISES SEGRO PRICE TARGET TO 995 (975) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY RAISES SMITHS GROUP TARGET TO 1,650 (1,480) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS M&G PRICE TARGET TO 205 (210) PENCE - 'HOLD'

----------

JEFFERIES RAISES J SAINSBURY PRICE TARGET TO 280 (270) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES FERGUSON PRICE TARGET TO 11,500 (10,900) PENCE - 'BUY'

----------

GOLDMAN RAISES UNITED UTILITIES PRICE TARGET TO 966 (962) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY RAISES COMPASS GROUP TARGET TO 1,450 (1,400) P - 'EQUAL-WEIGHT'

----------

GOLDMAN CUTS RIGHTMOVE PRICE TARGET TO 693 (712) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES 3I GROUP PRICE TARGET TO 1,340 (1,280) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

JEFFERIES RAISES CREST NICHOLSON TO 'BUY' ('HOLD') - TARGET 474 (358) PENCE

----------

JEFFERIES CUTS BELLWAY TO 'HOLD' ('BUY') - TARGET 3,820 (3,677) PENCE

----------

JPMORGAN RAISES BELLWAY PRICE TARGET TO 4,150 (3,500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES REDROW PRICE TARGET TO 750 (710) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES REDROW PRICE TARGET TO 751 (715) PENCE - 'BUY'

----------

JPMORGAN RAISES CREST NICHOLSON PRICE TARGET TO 320 (280) PENCE - 'UNDERWEIGHT'

----------

UBS RAISES GREGGS PRICE TARGET TO 2,430 (2,190) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS DIRECT LINE PRICE TARGET TO 350 (355) PENCE - 'BUY'

----------

HSBC CUTS HAYS TO 'HOLD' ('BUY') - TARGET 160 (153) PENCE

----------

JPMORGAN RAISES CINEWORLD GROUP PRICE TARGET TO 74 (50) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY RAISES CINEWORLD GROUP TARGET TO 50 (40) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES CUTS MORRISON SUPERMARKETS PRICE TARGET TO 235 (245) PENCE - 'BUY'

----------

JEFFERIES CUTS MONEYSUPERMARKET.COM PRICE TARGET TO 350 (400) PENCE - 'BUY'

----------

GOLDMAN RAISES CMC MARKETS PRICE TARGET TO 410 (395) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

MORGAN STANLEY CUTS FEVERTREE DRINKS TARGET TO 2,200 (2,300) P - 'EQUAL-WEIGHT'

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 1,560 (1,540) PENCE - 'BUY'

----------

RBC INITIATES ALLIANCE PHARMA WITH 'OUTPERFORM' - TARGET 106 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Jul 2020 10:24

Alliance Pharma revenues hit by Covid-19 in H1

(Sharecast News) - Healthcare group Alliance Pharma said on Tuesday that first-half revenues had been impacted by the Covid-19 pandemic, principally in its prescription medicines business.

Read more
28 Jun 2020 10:26

DIRECTOR DEALINGS: Alliance Pharma Chair Buys GBP100,000 In Shares

DIRECTOR DEALINGS: Alliance Pharma Chair Buys GBP100,000 In Shares

Read more
18 May 2020 10:51

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

Read more
11 May 2020 16:03

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Apr 2020 13:13

Alliance Pharma Withdraws Final Dividend Despite Strong 2019 Results

Alliance Pharma Withdraws Final Dividend Despite Strong 2019 Results

Read more
31 Mar 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Mar 2020 15:50

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
23 Mar 2020 18:12

Multiple UK Companies Warn On Covid-19 With Dividends Suffering

Multiple UK Companies Warn On Covid-19 With Dividends Suffering

Read more
17 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Jan 2020 11:32

Alliance Pharma lowers net debt after "strong" revenue growth in 2019

(Sharecast News) - International healthcare group Alliance Pharma said it had recorded some strong revenue growth in 2019 on Wednesday as well as a rapid reduction in net debt.

Read more
22 Jan 2020 10:54

Alliance Pharma Annual Revenue Rises On Strong Product Performances

Alliance Pharma Annual Revenue Rises On Strong Product Performances

Read more
3 Jan 2020 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
12 Dec 2019 16:11

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
27 Nov 2019 15:00

Alliance Pharma handing back 'Xonvea' rights to Duchesnay

(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.

Read more
27 Nov 2019 12:33

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.